The presence of BRAF mutation in BCPAP and SW1736 can aberrantly activate HIF pathway independent of hypoxia, promoting overactive MEK/EPK signalling which results in increased HIF protein synthesis, suggesting that activation of the HIF pathway is essential in thyroid cancer progression [8]. This evidence concerns the gene MAP2K7 and thyroid cancer.